Published in Pflugers Arch on September 06, 1978
Vasopressin release by nicotine: the site of action. Br J Pharmacol (1975) 2.61
Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol (1980) 1.59
Pharmacological analysis of the acute inflammatory process induced in the rat's paw by local injection of carrageenin and by heating. Br J Pharmacol (1973) 1.32
Increases in fines and driver licence withdrawal have effectively reduced immediate deaths from trauma on Brazilian roads: first-year report on the new traffic code. Injury (2001) 1.11
Comparative pharmacological actions of bradykinin and related kinins of larger molecular weights. Biochem Pharmacol (1971) 1.07
Effect of anti-proteases and hexadimethrine bromide on the release of a bradykinin-like substance during heating (46 degrees C) of rat paws. Br J Pharmacol (1970) 1.07
Vasopressin clearance and secretion during haemorrhage in normal dogs and in dogs with experimental diabetes insipidus. J Physiol (1972) 0.98
Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom. Experientia (1965) 0.96
Effect of hypertonic sodium chloride (7.5%) on uncontrolled hemorrhage in rats and its interaction with different anesthetic procedures. Circ Shock (1992) 0.96
Vasopressin release produced in anaesthetized cats by antagonists of gamma-aminobutyric acid and glycine. Br J Pharmacol (1978) 0.96
A brief survey of the history of inflammation. 1978. Agents Actions (1994) 0.95
Inhibition of vasopressin release to carotid occlusion by gamma-aminobutyric acid and glycine. Br J Pharmacol (1981) 0.94
The tachyphylactic effect of barium on intestinal smooth muscle. Arch Int Pharmacodyn Ther (1973) 0.94
Hypertonic and hyperoncotic resuscitation from severe hemorrhagic shock in dogs: a comparative study. Crit Care Med (1989) 0.93
Hypertonic saline and pentoxifylline prevent lung injury and bacterial translocation after hemorrhagic shock. Shock (2000) 0.93
Release of kinins from fresh plasma under varying experimental conditions. Biochem Pharmacol (1967) 0.92
Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock (1997) 0.91
Catatonia induced in the rabbit by intracerebral injection of bradykinin and morphine. Eur J Pharmacol (1971) 0.86
On the role of vasopressin and angiotensin in the development of irreversible haemorrhagic shock. J Physiol (1974) 0.85
A brief survey of the history of inflammation. Agents Actions (1978) 0.84
Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World J Surg (1998) 0.83
Effects of intra-aortic balloon occlusion on intestinal perfusion, oxygen metabolism and gastric mucosal PCO2 during experimental hemorrhagic shock. Eur Surg Res (2004) 0.83
Hemodynamic effects of hypertonic sodium chloride during surgical treatment of aortic aneurysms. Surgery (1987) 0.82
Pharmacologial analysis of the mediators involved in the acute pulmonary edema produced in rats by adrenaline. Agents Actions (1973) 0.82
Brain kinins and fever induced by bacterial pyrogens in rabbits. J Pharm Pharmacol (1975) 0.81
Hyperosmotic NaCl and severe hemorrhagic shock: role of the innervated lung. Am J Physiol (1981) 0.80
Potentiation of the cerebral vascular action of bradykinin by the 'bradykinin potentiating factor' (BPF) in the dog. Experientia (1965) 0.80
Thermal filament continuous thermodilution cardiac output delayed response limits its value during acute hemodynamic instability. J Trauma (1999) 0.79
Influence of temperature on recovery of inhibition by antihistaminics and -haloalkylamines toward histamine. Eur J Pharmacol (1972) 0.79
Active spleno-femoral shunt avoids splanchnic congestion during portal triad occlusion: an experimental study. Transplant Proc (2005) 0.79
Hypertonic acetate-alpha alpha hemoglobin for small volume resuscitation of hemorrhagic shock. Artif Cells Blood Substit Immobil Biotechnol (1997) 0.78
Pressure-driven hemorrhage: a new experimental design for the study of crystalloid and small-volume hypertonic resuscitation in anesthetized dogs. Circ Shock (1992) 0.78
Concerning the histamine receptor (H1). J Pharm Pharmacol (1969) 0.78
Central angiotensinergic system and hypertonic resuscitation from severe hemorrhage. Am J Physiol (1990) 0.78
Radioisotope blood volume measurement in uncontrolled retroperitoneal haemorrhage induced by a transfemoral iliac artery puncture. Injury (2001) 0.77
Hemodynamic and metabolic effects of CO2 pneumoperitoneum in an experimental model of hemorrhagic shock due to retroperitoneal hematoma. Surg Endosc (1998) 0.76
The secretion and clearance of vasopressin during the development of irreversible haemorrhagic shock. J Physiol (1971) 0.76
Is aortic occlusion advisable in the management of massive hemorrhage? Experimental study in dogs. Shock (1998) 0.76
Influence of pH on the inhibitory action of local anaesthetics on smooth muscle contraction. Br J Pharmacol (1970) 0.75
A pharmacological analysis of the mode of action of serotonin (5-hydroxytryptamine) upon the guinea-pig ileum. 1952. Br J Pharmacol (1997) 0.75
Apnea, bradycardia, hypotension and muscular contraction induced by intracarotid injection of bradykinin. J Pharmacol Exp Ther (1974) 0.75
Hypertonic NaCl solution prevents bupivacaine-induced cardiovascular toxicity. Circ Shock (1992) 0.75
On the nature of the antagonism atropine-acetylcholine on the guinea pig heart. Acta Physiol Lat Am (1977) 0.75
Effects of hypertonic sodium chloride solution on the electrophysiologic alterations caused by bupivacaine in the dog heart. Braz J Med Biol Res (2003) 0.75
Pharmacological actions of proteolytic enzymes (proteases). Ann N Y Acad Sci (1968) 0.75
GABA and glycine inhibit vasopressin release to carotid occlusion [proceedings]. J Physiol (1979) 0.75
Anti-inflammatory action of sulfated polysaccharides. Biochem Pharmacol (1969) 0.75
Current topics in kinin research. Opening remarks. Adv Biosci (1978) 0.75
A thermodynamic approach to problems of drug antagonism. Measurements of the parameters of affinity (pA2) of antihistaminics and a beta-haloalkylamine under varying experimental conditions. Eur J Pharmacol (1974) 0.75
Hepatic arterial buffer response fails to restore hepatic oxygenation after temporary liver dearterialization in canines. Transplant Proc (2005) 0.75
Presentation of a film on the "Central effects of bradykinin". Adv Exp Med Biol (1979) 0.75
[Early hemodynamic effects of the rapid infusion of sodium chloride Dextran-70 hypertonic solution as treatment for hemorrhagic shock in dogs]. Arq Bras Cardiol (1993) 0.75
Present trends of kinin research. Life Sci (1974) 0.75
Bradykinin release into portal blood during haemorrhagic shock [proceedings]. J Physiol (1979) 0.75
Which is the effective agent-bradykinin or prostaglandins-on the isolated mammalian heart. Adv Exp Med Biol (1976) 0.75
[Science and humanism]. Rev Bras Med (1967) 0.75
Studies on the activation of the pre-kininogenin-kininogenin (pre-kallikrein-kallikrein) system by sulfated polysaccharides and kaolin. Adv Biosci (1978) 0.75
Myocardial reperfusion: leukocyte accumulation in the ischemic and remote non-ischemic regions. Shock (2000) 0.75
Release of kinin-like material in rats submitted to hyperthermia (40-43 degrees C). Agents Actions (1973) 0.75
Pharmacology of venoms--introductory remarks. Mem Inst Butantan (1966) 0.75
Release of kinins by acidified bovine pseudoglobulin. Biochem Pharmacol (1971) 0.75
Systemic and regional hemodynamic effects of enalaprilat infusion in experimental normotensive sepsis. Braz J Med Biol Res (2006) 0.75
Bradykinin derivatives as permeability factors. Agents Actions (1973) 0.75